Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

Lipotoxicity and the gut-liver axis in NASH pathogenesis

(2018) Fabio Marra et al.   JOURNAL OF HEPATOLOGY

Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis

(2018) Haitao Pan et al.   Marine Drugs

Systems biology in hepatology: approaches and applications

(2018) Adil Mardinoglu et al.   Nature Reviews Gastroenterology & Hepatology

Triggering and resolution of inflammation in NASH

(2018) Susanne Schuster et al.   Nature Reviews Gastroenterology & Hepatology

Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

(2018) Yibo Bai et al.   Marine Drugs

q2-longitudinal: Longitudinal and Paired-Sample Analyses of Microbiome Data

(2018) Nicholas A. Bokulich et al.   mSystems

Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison

(2017) Patrick Leuthold et al.   JOURNAL OF PROTEOME RESEARCH

Functional Comparison for Lipid Metabolism and Intestinal and Fecal Microflora Enzyme Activities between Low Molecular Weight Chitosan and Chitosan Oligosaccharide in High-Fat-Diet-Fed Rats

(2017) Chen-Yuan Chiu et al.   Marine Drugs

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chitosan oligosaccharide: Biological activities and potential therapeutic applications

(2017) Chatchai Muanprasat et al.   PHARMACOLOGY & THERAPEUTICS

Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation

(2017) Linlin Wang et al.   Food & Function

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)

(2017) Qian Chen et al.   Nutrients

Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity

(2016) Phillipp Hartmann et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation

(2016) Lirui Wang et al.   Cell Host & Microbe

Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) A. Lonardo et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

(2016) Jérôme Boursier et al.   HEPATOLOGY

Natural Products with Anti-obesity Effects and Different Mechanisms of Action

(2016) Chuhan Fu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Plasma Lipidomics Investigation of Hemodialysis Effects by Using Liquid Chromatography–Mass Spectrometry

(2016) Lichao Wang et al.   JOURNAL OF PROTEOME RESEARCH

Non-alcoholic fatty liver disease and dyslipidemia: An update

(2016) Niki Katsiki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

Structural and biochemical insights into the degradation mechanism of chitosan by chitosanase OU01

(2015) Qianqian Lyu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice

(2015) Magdalena Mazagova et al.   FASEB JOURNAL

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2015) Sumio Watanabe et al.   HEPATOLOGY RESEARCH

Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats

(2015) Lanlan Huang et al.   Marine Drugs

Impact of human milk bacteria and oligosaccharides on neonatal gut microbiota establishment and gut health

(2015) Ted Jost et al.   NUTRITION REVIEWS

Structural insights into the substrate-binding mechanism for a novel chitosanase

(2014) Qianqian Lyu et al.   BIOCHEMICAL JOURNAL

Interactions Between the Intestinal Microbiome and Liver Diseases

(2014) Bernd Schnabl et al.   GASTROENTEROLOGY

Clinical approaches to non-alcoholic fatty liver disease

(2014) Katherine JP Schwenger   WORLD JOURNAL OF GASTROENTEROLOGY

Data, information, knowledge and principle: back to metabolism in KEGG

(2013) Minoru Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Vitamin E and nonalcoholic fatty liver disease

(2012) Tommy Pacana et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis

(2012) David Berry et al.   ISME Journal

Inhibition of Bladder Tumor Growth by Chitooligosaccharides in an Experimental Carcinogenesis Model

(2012) João Fernandes et al.   Marine Drugs

Global metabolic profiling of animal and human tissues via UPLC-MS

(2012) Elizabeth J Want et al.   Nature Protocols

Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation

(2012) Eun Hye Choi et al.   NUTRITION RESEARCH

Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats

(2011) Daxin Wang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Anti-Inflammatory Activity of Chitooligosaccharides in Vivo

(2010) João C. Fernandes et al.   Marine Drugs